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Abstract 
While life expectancy has increased worldwide during the last decades, the developing 
world is still losing millions of lives each year due to three pervasive illnesses: Malaria, 
HIV and Chronic Malnutrition. This work analyzes the observed trade-offs between 
health investments on these three conditions and their incidence in Ghana and Nigeria 
during the period 2005-2015.  We use data from the OCDE credit report system database 
together with data on incidence from the World Health Organization, World Bank, Global 
Fund and the Bill and Melinda Gates Foundation. Results of the cross-data analysis show 
that: (i) the largest investments go to HIV in both countries, (ii) both malaria and HIV 
receive investments much larger than those directed to malnutrition, even when the 
incidence of chronic malnutrition is larger  (Ghana), (iii) investments in malaria are larger 
in Ghana than in Nigeria despite that malaria incidence is higher in Nigeria, and (iv) the 
Southern states of both countries receive larger health investments in detriment of the 
poorest Northern areas. We identify and discuss several factors that may explain the 
mismatch between health funds and incidence for these conditions as well as the 
apparently low investments in chronic malnutrition in comparison to HIV and Malaria.  
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1. Introduction 
Since the beginning of the HIV/AIDS epidemic, funds towards combating this disease 
haven increased systematically, although at a decreasing rate in the last years. The fact 
that this condition was affecting not only developing countries but also developed 
countries got the allocation of more resources than ever to the health sector all around the 
world, thanks to the involvement of multilateral and bilateral organizations as well as 
foundations such as Bill and Melinda Gates Foundation, the Bill Clinton Foundation, and 
the creation of the Global Fund, focused on HIV/AIDS, Malaria and TB. The amount of 
funds devoted to HIV/AIDS reached such levels that in several sub-Saharan African states 
investments approximate or exceed the entirety of their national budgets (Shiffman, 
2008). Such massive investments were beneficial to attract more attention from the donor 
community to health related issues, but it also produced displacement effects since the 
growing share of HIV/AIDS as a share of total health aid was accompanied by global 
stagnation in  health population aid, and decreased the attention towards malaria fighting 
(Shifftman, 2006, Lordan et al , 2011).  
  
But HIV/AIDS is not the only condition that causes millions of deaths in Sub-Saharan 
Africa, malaria and chronic malnutrition incidence are very high in this part of Africa 
(and in many other developing regions around the world). The fight against malaria 
started later than the fight against HIV/AIDS, but has yielded dramatic progress over the 
last 10–15 years (USAID, 2015)). The World Health Organization (WHO) estimates that 
the scale-up of malaria control interventions between 2001 and 2013 resulted in an 
estimated 4.3 million fewer malaria deaths. These impressive results – particularly in sub-
Saharan Africa – are due to a massive scale-up of malaria prevention and case 
management measures resulting from the combined efforts of national malaria control 
programs (NMCPs), a broad range of partners, and the launch of three major initiatives: 
the Global Fund to Fight AIDS, Tuberculosis and Malaria in 2002, The World Bank 
Malaria Booster Program in 2004, and the U.S. President’s Malaria Initiative (PMI) in 
2005. More recently, The Bill & Melinda Gates Foundation has adopted malaria 
eradication as its primary goal. This shift also is reflected in the Roll Back Malaria 
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Partnership’s draft second Global Malaria Action Plan 2, 2016–2030 (GMAP 2) and 
WHO’s draft Global Technical Strategy (GTS). These efforts have led to the eradication 
of malaria in 17 countries, between 2000 and 2015.  Despite these achievements, there 
are still voices that claim that malaria is still underfunded relative to its share of disease 
burden (Shifftman 2006, WHO,2016).  
Investments in chronic malnutrition have been way below investments in HIV/AIDS or 
malaria. Nutrition has been a neglected area of global health and development, accounting 
for less than 1 percent of global foreign aid. This is largely due to its underlying and often 
hidden role in child illnesses and deaths. Nutrition-related factors contribute to about 45 
percent of child deaths under age 5. Among undernourished children who survive, more 
than one quarter suffer from stunted growth, which can impair neurological development 
and learning. 
 
The objective of this paper is to analyze funding trends regarding HIV, malaria and 
malnutrition in two countries of Sub-Saharan Africa. The final objective of this study is 
to determine whether the allocation of resources has been done effectively in order to 
prevent and battle these diseases, allocating more resources to the areas of higher 
incidence.. Nigeria is the most populous country and the largest economy of the African 
continent; in addition, the country shows growing incidence of HIV and Malaria despite 
significant investments to fight these diseases. Malnutrition is also very high.  Ghana is 
close to Nigeria not only geographically but also in terms of the incidence of these 
conditions. 
The analysis is based on two main databases: one for the health investments reported by 
the OECD credit repot system and another one for the incidence of Malaria and HIV by 
WHO and the WB. In addition, another database has been used in order to retrieve the 
data of refugees by the UNHCR, as a complement to the analysis of Nigeria, where the 
conflict of Boko Haram is causing significant implications in health and health 
investments. 
The structure followed is the following:  first, we begin with a brief description of the 
selected diseases and countries (Section 2. Background). Section 3 focus on the data and 
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methodology used. Section 4 presents the results. Finally, section 4 discusses the results 
and concludes.   
 2. Background 
2.1. Malaria, HIV and Malnutrition  
Malaria   
Malaria is a preventable and treatable infectious disease caused by parasites of the 
Plasmodium family and transmitted by female Anopheles mosquitoes. There are four 
different malaria species: P. falciparum, P. vivax, P. malariae and P. ovale. The first two 
are the most prevalent species of malaria and P. falciparum is the most dangerous. P. 
knowlesi is a zoonotic plasmodium that is also known to infect humans (WHO, 2016) 
Many medical advancements have been made in order to prevent, diagnose and treat 
malaria. The main methods used for the prevention of malaria are long-lasting insecticidal 
nets (LLINs), indoor residual spraying (IRS) in which insecticides are sprayed on the 
walls of homes, and intermittent preventive treatment for pregnant women (IPTp) (Roll 
Back Malaria Partnership, 2008). Despite the efforts of the last years in the development 
of a vaccine against malaria, nowadays there is no licensed malaria vaccine. The 
RTS,S/AS01 is the most advanced vaccine against the most dangerous specie, the P. 
falciparum. Researches to find a vaccine against malaria are currently taken and more 
than 20 other vaccines are being evaluated as we can see in (Annex 5) (WHO, 2016). 
Malaria kills each year more than one million people, the majority in sub-Saharan Africa, 
where malaria is the leading cause of death for children under five. In fact, more than 
90% of malaria deaths occur in Sub-Saharan Africa; where Nigeria and Democratic 
Republic of the Congo account for about the 40% of estimated mortality due to malaria 
worldwide. In addition, half of the world’s population, 3.2 billion people, is at risk of 
infection (Roll Back Malaria Partnership, 2017).  
The population with the highest biological risk of getting infected by malaria are infants 
and young children (from six months to five years), pregnant women, non-immune people 
(as for travelers, laborers and populations moving from low-transmission to high-
transmission areas) and people living with HIV/AIDS (Roll Back Malaria Partnership, 
2008).  Malaria is a global emergency that perpetuates a vicious cycle of poverty in the 
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developing world. For this reason, malaria has been a main point of the discussion among 
international institutions working on development. Actually, it was present in the 
Millennium Development Goals (MDG) in 2000 and it is a target of the Sustainable 
Development Goals (SDG) in 2015 of the United Nations. Target 6.C of the MDG was 
to have halted by 2015 and begun to reverse the incidence of malaria and other major 
diseases. The SDG take a step forward and in Goal 3 (Ensure healthy lives and promote 
well-being for all at all ages) they include the target of ending by 2030 the epidemics of 
malaria among other diseases. 
In addition, the Global Technical Strategy for Malaria 2016-2030 by the World Health 
Organization provides guidance to countries and development partners towards the 
elimination of malaria. The target proposed is to reduce malaria by 90% by 2030 and for 
arriving there they highlight the need of increasing investments in preventive measures, 
diagnostic testing, treatment, disease surveillance, innovation and research.  
The endeavors made in reducing malaria incidence and mortality since 2000 were 
possible due to the large increases in the financing of malaria control and elimination 
programs. In fact, investments in malaria control for developing countries went up from 
$201533 million in 2002 to $20151.8 billion in 2015. During the first years, most efforts 
focused on India, that received more than the 60% of the investments.. Nevertheless, 
nowadays the focus is on Africa where more than the 80% of 2015 investments were 
incurred (OECD, 2016). The investments made in battling malaria between 2001 and 
2015 contributed to reduction of malaria mortality rates almost by half, a 47%. In Africa, 
the reduction was even higher when referring to one of the most vulnerable populations 
to malaria, children under 5 years, with a reduction of 58%.  Moreover, the incidence of 
malaria was reduced by 30% during the same period. 
Coordination among international institutions and affected countries is crucial for the 
eradication of this preventable and treatable infectious disease.   
 HIV/AIDS 
HIV corresponds to the acronym Human Immunodeficiency Virus. This virus targets the 
immune system and weakens people's defense systems by destroying and impairing the 
function of immune cells. It is measured by the CD4 cell count (WHO, 2016). 
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AIDS corresponds to the acronym Acquired Immunodeficiency Syndrome, which is the 
most advanced stage of HIV infection. It is defined by the development of certain cancers, 
infections, or other severe clinical manifestation, which can arise, depending on the 
characteristics of the individual, in various times of HIV; usually between the second and 
the fifteenth year of the disease (WHO, 2016).  
The transmission of HIV can be through the exchange of a variety of body fluids from 
infected individuals as for semen, vaginal secretions, blood and breast milk. HIV is a non-
curable disease but treatable with effective antiretroviral drugs (ARV), which helped in 
control of the virus and prevent its transmission. According to WHO’s estimations, only 
a 60% of HIV infected people currently know their status (WHO, 2016) 
HIV has a high incidence worldwide, in fact, approximately 37 million people are 
currently infected with HIV, from which 2 million people were infected with the disease 
in 2015. Moreover, more than 35 million people have lost their life due to HIV, from 
which 1.1 million died in 2015. The world’s region with the highest number of infected 
people is Sub-Saharan Africa, where more than the 70% of HIV infected people live, 
more than 25 million people, in 2015. In addition, Sub-Saharan Africa is also the region 
with the highest number of HIV new infections, accounting for the two thirds of new 
global infected people in 2015, around 1.3 million people. 
The prevention of HIV is based in the following actions: male and female condom use; 
testing and counselling of HIV and STI (Sexually Transmitted Infections); testing and 
counselling of TB (Tuberculosis, leading cause of death among HIV infected people); 
voluntary male medical circumcision (reduces de risk of infection in male up to a 60%); 
prevention with Antiretroviral (ARV) drugs (reducing the risk of transmission by 96%); 
harm reduction for injecting drug users (i.e. needle and syringe programs, information 
and education, etc.); and the elimination of mother to child transmission (EMTCT) of 
HIV (by the prevention with ARVs to the mother and the child during pregnancy, labor 
and post-natal period). 
International bodies have made different efforts in order to reduce the incidence of HIV 
over the years. In fact, HIV was present in goal 6 of the Millennium Development Goals, 
‘Combat HIV/AIDS, Malaria and other diseases’, where the Target A exposed as a goal 
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to have halted the between 1990 and 2015, and begun to reverse the spread of HIV/AIDS; 
and in Target B stated the achievement by 2010 of universal access to treatment. The 
targets were partially fulfilled, as for the decrease in the number of new infected people, 
which fell around 40% between 2000 and 2013; and the increase in the number of ARV 
treated people. Sustainable Development Goals have continued the path of MDG but with 
a more ambitious goal: Goal 3, ‘Ensure healthy lives and promote well-being for all at all 
ages’, where target is to end the epidemic of AIDS by 2030. 
Another relevant international commitment for the battle against HIV was the "Global 
Health Sector Strategy on HIV for 2016-2021" concluded at the sixty-ninth World Health 
Assembly (WHA) that established the steps to follow in order to accomplish the specific 
targets of the SDG. 
In addition, the United Nations Population Fund (UNFPA) battles against HIV with its 
co-sponsor UNAIDS. The mission of UNFPA’s programs is halting the new infections of 
HIV, discrimination and AIDS related deaths by the promotion of human rights, the 
reduction of inequalities UNAIDS offers another strategy to battle HIV, the 90-90-90 by 
2020. The ambitious plan settles that by 2020 90% of all people living with HIV will 
know their status; 90% of all people with diagnosed HIV infection will receive sustained 
antiretroviral therapy; and 90% of all people receiving antiretroviral therapy will have 
viral suppression. 
In fact, investments in HIV for developing countries went up from $2015 1.1 billion in 
2002 to $2015 6.2 billion in 2015. The efforts where focused in Africa since the beginning, 
with an increasing share of the percentage of investments in developing countries from 
more than a 35% in 2002 to more than the 55% in 2015.  
HIV/AIDS is among the three diseases studied the one with the highest investments in 
developing countries worldwide since the beginning.   
Malnutrition 
Malnutrition alludes to deficiencies, excesses or imbalances in a person’s intake of energy 
and/or nutrients. Two groups are distinguished among malnutrition conditions, 
undernutrition and overweight. Undernutrition is comprised of stunting (low height for age), 
wasting (low weight for height), underweight (low weight for age) and micronutrient 
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deficiencies or insufficiencies (a lack of important vitamins and minerals). On the other 
hand, overweight involves obesity and diet-related noncommunicable diseases (as for 
heart diseases, stroke, diabetes and cancer). During this study we will put the emphasis 
on the first group, under-nutrition, and more concretely in stunting (height for age). 
Stunting is an under-nutrition disease. It alludes to the insufficient height of a child for 
his or her age as result of chronic or recurrent malnutrition. Stunting affects not only the 
physical conditions of a child but also his/her cognitive skills; in addition to a reduced 
productive capacity, poor health and an increased risk of degenerative diseases such as 
diabetes. The factors that contribute to stunted growth and development include poor 
maternal health and nutrition, inadequate infant and young child feeding practices, and 
infection.  
In 2015, two out of ten children under five were considered stunted. In fact, in 2015, 156 
million children under five suffered from stunting worldwide from which a 56% lived in 
Asia and 37% in Africa. Progress has been made since 2000 regarding stunting rates, 
from 198 to 156 million stunted children, nonetheless this progress has not been the same 
in all regions. Actually, from 2000 to 2015, Asia and Latin America and Caribbean 
managed to diminish stunting rates by over one third whereas Africa’s reduction during 
the same period was of one sixth.  Even though, stunting rates are diminishing over time 
in all regions, the number of African stunted children is increasing, in 2015 there were 8 
million stunted children more than in 2000, from which 4 million lived in Western Africa. 
Researches show that the first 1,000 days, since the pregnancy of the mother until the two 
years of the child, are crucial for his/her development. As mentioned before, stunted 
children have weaker immune systems, which makes them more susceptible to death and 
diseases. They also have a diminished cognitive capacity, which impacts their ability to 
learn and develop; and therefore, in their ability to earn higher incomes later in life, 
generating a poverty trap.  
International bodies have made different efforts in order to reduce the incidence of 
stunting over the years. In fact, stunting was present in goal 1 of the Millennium 
Development Goals, ‘Eradicate extreme poverty and hunger’, where the Target C 
exposed to reduce by half, between 1990 and 2015, the proportion of people who suffer 
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from hunger. Stunting is not mentioned specifically, but it was covered by the MDG of 
the United Nations. Sustainable Development Goals have continued the path of MDG but 
with a more ambitious goal: Goal 2, ‘End hunger, achieve food security and improved 
nutrition, and promote sustainable agriculture’, where Target 2.1. establishes the end by 
2030 of all forms of malnutrition.  
In addition, since 2012 the 194 member states of the World Health Assembly have joined 
their efforts and they have established several targets to improve nutrition towards the 
horizon 2025 focusing on six areas: stunting, exclusive breastfeeding, wasting, anemia, 
low birth weight, and overweight. Regarding the area of stunting, the target to achieve is 
the reduction of a 40% the number of children under five stunted, which accounts for at 
least 65 million fewer stunted children in 2025, with an estimated investment of 
$49.5billion. The actions determined in order to arrive to the target established are the 
following: an antenatal micronutrient supplementation for 180 days per pregnancy, the 
promotion of good infant and young child nutrition and hygiene practices, a balanced 
energy-protein supplementation for pregnant women living under the poverty line, an 
intermittent preventive treatment for malaria in pregnancy, vitamin A supplementation 
for children of 6 to 59 months, prophylactic zinc supplementation for children of 6 to 59 
months, public provision of complementary foods for children of6 to 23 months living 
under the poverty line.  
The endeavors made in reducing the incidence of stunted children were possible due to 
the large increases in the financing of basic nutrition programs as the ones mentioned 
above. In fact, investments in basic nutrition for developing countries went up from 
$2015142 million in 2002 to $2015866 million in 2015. The efforts where focused the very 
first years in South and Central Asia, where more than the 40% of the investments were 
made in 2002, centering the attention in India where the figure was 30%; facing the 27% 
of Africa. Nevertheless, nowadays the contrary situation occurs, the focus is on Africa 
where more than the 50% of 2015 investments were incurred, facing the 30% of Asia, 
that currently is more spread among the continent. 
Despite the increase of investments in basic nutrition over time, if we compare them to 
the investments made in malaria, we are far behind, almost a billion US dollars at constant 
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prices of 2015. Stunting is a problem faced by millions of children and that is restraining 
development in poor countries and urgent action needs to be taken. 
 
3. Data and methodology 
We build up our analysis on two main databases, one for the health investments reported 
by the OECD credit repot system and another one for the incidence of Malaria, HIV and 
Chronic Malnutrition by the WHO and the WB. In addition, another database has been 
used in order to retrieve the data of refugees by the UNHCR, as a complement to the 
analysis of Nigeria, where the conflict of Boko Haram is causing significant implications 
in health and health investments.  
3.1.Donations Data 
The data used mainly in the section of Donations Data is extracted from the website of 
the OECD (Organization for Economic Co-Operation and Development), the OECD.Stat. 
The database includes a variety of data on different topics as for Economy, Agriculture, 
Development, Education, Energy, Environment, Finance and Government.  
The selected variable for this study project has been Development, based on Development 
resource flows and Official Development Assistance (ODA). Concretely, this study 
analysis focuses on the individual project flows and Creditor Reporting System (CRS). 
As it is described in the OECD’s website, the objective of the CRS Aid Activity database 
is to provide a set of readily available basic data that enables analysis on where aid goes, 
what purposes it serves and what policies it aims to implement, on a comparable basis 
for all DAC members. Data are collected on individual projects and programs.  
In order to extract the data of interest several filters have been selected. Firstly, we have 
selected Official Development Assistance as main flow, All Channels of aid (Private 
Public Partnerships (PPP), Public Sector, NGOs, Multilateral Organizations) and all types 
of aid (Project Type Interventions, Budget Support, etc.). 
In addition, the data is expressed in constant prices, more concrete, in US Dollars of 2014. 
In the dataset, the amount of USD is represented in millions of USD2014, but in this project, 
we will mention thousands of USD2014. Moreover, the flow type selected is Gross 
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Disbursements. This means that the amounts of the dataset are resources which have been 
distributed to a recipient country in a given year. The reasoning behind the selection of 
Gross Disbursements over Commitments is that the aim of the project is to extract 
conclusions based on the analysis of the investments really accomplished in the recipient 
country, not the committed ones.   
The Regions of interest selected for the study of first, an overview of the developing 
world, and then, the country specific investments, are the following: 
o Developing 
Countries Total 
o Africa Total 
o America Total 
o Nigeria 
o Ghana 
In this project, we will study the main Health Investments in the selected countries and 
regions. Therefore, the different ‘Sectors’ selected in the dataset reflect this objective. 
Each sector defines the economic or social mission of the investments. In particular, the 
studied sectors are the following 4: 
- 120. I.2. Health, Total: including both, general and basic health. In the section of 
General Health, we can find a variety of subsectors as for Health Policy and 
Administration Management, Medical Education and Training, Medical Research and 
Medical Services. Regarding the section of Basic Health, we find subsections as for Basic 
Health Care, Basic Health Infrastructure, Basic Nutrition, Infectious Disease Control, 
Health Education, Malaria Control, Tuberculosis Control and Health Personnel 
Development. 
An important modification made for this specific study, with the objective of making 
more complete and accurate to reality this variable, is to sum up to the amount of 
investments Health Total the investments devoted to battle Sexually Transmitted Diseases 
(STD). Currently, this line item of investment has been crucial for the Aid of 
Development in Health Issues, and therefore it would not be accurate to talk about Health 
Total investments without including STD investments, mainly devoted to fight HIV. The 
variable used for this study is Health Total (including HIV/AIDS), of own elaboration. 
- 12240. Basic Nutrition: Part of the Subsection of Basic Health in Health Total. This 
variable includes all investments made in order to guarantee the basic nutrition and 
nourishment of the population. 
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- 12262. Malaria control: Part of the Subsection of Basic Health in Health Total. This 
variable includes investments made in order to ensure the battle against this disease. 
- 13040. STD Control including HIV/AIDS: Part of the Subsection of Population 
Policies/Programs & Reproductive Health Total. This variable includes the total amount 
of investments devoted to battle Sexually Transmitted Diseases (STD), the major part of 
the resources in this issue are devoted to fight against HIV, therefore we consider this 
variable as the referent variable for the battle against HIV.  
The study uses data of the last 10 consecutive years from 2006 to 2015, both included.  
3.2. Health Indicators 
With the aim of gathering data for the incidence of the three main health issues studied, 
malaria, HIV and malnutrition, in Ghana and Nigeria, two databases were consulted: the 
dataset of the World Bank and the World Health Organization dataset. 
This case study formulates the evolution of five health variables over a time-lapse of 10 
years (2005-2015) with the intention of describing the incidence of these health issues 
regionally and in the two countries of interest, Nigeria and Ghana. As result of the use of 
two different databases, the regions used to explain a global situation of the health issue 
are slightly different. On the one hand, we find as regions of interests Sub-Saharan Africa, 
Latin-American & Caribbean and Low & Middle Income Countries Total for some 
variables. On the other hand, we described as important regions Africa Total, America 
Total and Developing Countries Total for the remaining variables. The difference among 
them are minimal in the topic of incidence of these health problems (Malaria, HIV and 
Stunting) because those are mainly a developing countries’ issue, therefore we can 
consider that they comparable among them, and also similar to the developing regions of 
the section for investments. 
Developing Countries, Africa and Latin-America have been selected as regions of study 
in order to contextualize the incidence of the illnesses in the World. Even though our 
focus of study is Ghana and Nigeria in Africa, we obtain data from Africa in general ( in 
addition to the data from Ghana and Nigeria) and we also obtain data Latin America as a 
region.  Nonetheless, the selection of Latin America as a region of study has the objective 
of seeing from another angle the health issues covered in this study and compare the 
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region of Africa to other developing regions of the world. Latin Americas is a more 
developed region than Africa, whose incidence in malaria, malnutrition and HIV is also 
significant. We use the data of Latin America in order to have it as a reference to other 
developing regions with the same health issues but with a different level of development.  
The five health variables (Prevalence of stunting, malaria incidence, malaria nº of 
reported deaths, malaria nº of reported cases, HIV incidence) have been extracted primary 
from the two databases explained before, but in the case of malaria another source has 
been part of the project in order to complete the dataset, the Malaria Report of 2016, by 
the WHO. 
- Prevalence of stunting, height for age (% of children under 5): which measures the 
prevalence of child malnutrition as the percentage of children under age 5 whose height 
for age (stunting) is more than two standard deviations below the median for the 
international reference population ages 0-59 months. Two different sources of the World 
Bank DataBank have been used for this variable: the Subnational Malnutrition database 
for the regional data of Ghana and Nigeria and the Health Nutrition and Population 
Statistics for the national average data of both countries. In addition, with the dataset of 
the WHO information about Developing Countries, Africa and America was obtained. 
- Incidence of Malaria: is the number of new cases of malaria in a year per 1,000 
population at risk. The incidence of malaria was obtained from the World Development 
Indicators, one of the sources of the DataBank of the World Bank. 
- Malaria number of deaths: Two different variables are showed in these graphs, the 
number of reported deaths and the number of estimated deaths due to malaria in a given 
year, with a significant difference among them, mainly due to the lack of reporting deaths. 
In poor countries as the ones studied the reporting indexes are very low and even lower 
when it refers to the cause of death.  
- Malaria number of cases: as in the case of malaria deaths, two different variables are 
showed in these graphs, the number of reported cases and the number of estimated cases 
of malaria in a given year, with a significant difference among them, mainly due to the 
low reporting indexes and the lack of resources.  
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For the previous variables, numbers of deaths and cases of malaria, two datasets have 
been used. Firstly, for the number of reported cases and deaths the main source of 
information was the DataBank of the WorldBank (Health, Nutrition and Population 
Statistics; Africa Development Indicators) and it was completed with the Malaria Report 
2016 edited by the WHO and the WHO dataset. On the other hand, the estimations about 
the number of malaria cases and deaths were obtained by a unique source the WHO 
dataset, which included estimations for the margins of error, represented in the graph. The 
estimations are for three specific years 2005, 2010 and 2013; and only for the two 
countries of interest Ghana and Nigeria. 
- Incidence of HIV (% of uninfected population ages 15-49): Number of new HIV 
infections among uninfected populations ages 15-49 expressed as percentage. It was 
obtained from the Health, Nutrition and Population Statistics’ source of the WorldBank’s 
DataBank. 
3.3 Refugees and IDPs 
In addition, I considered the information of refugees and IDPs of Nigeria due to the 
current violent situation with the Boko-Haram’s conflict in the North-East part of the 
country. I realized during my study that the most violent areas of the country were 
suffering a striking situation of malnutrition jointly with the adjoining countries of asylum 
as Niger, Cameroon and Chad. The purpose of including this new variable to the study is 
to see if the investments made in malnutrition matched with the critical situation that the 
area is suffering.  
Therefore, the information about the refugees and Internally Displaced Persons has been 
an additional part of interest for this project. Two main sources have been used for this 
purpose the Statistics Database of the United Nations Refugee Agency (UNHCR) in 
Spain called ACNUR and the 2015 Revision of World Population Prospects by the 
Department of Economics & Social Affairs of the United Nations. 
The variables of interest for this analysis were two, the number of Nigerian refugees and 
IDPs and its places of asylum, both retrieved form the UNHCR’ Statistics Database, with 
data of 2015. 
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- Nigerian refugees, asylum-seekers, internally displaced persons (IDPs), returnees 
(refugees and IDPs), stateless persons, and others of concern to UNHCR, end-2015 
In this database, we can find information about asylum-seekers, refugees, IDPs and others 
in the year ended 2015. The UNHCR provides the following descriptions about the main 
variables used in this study (refugees and IDPs): 
o Refugees “include individuals recognized under the 1951 Convention relating to 
the Status of Refugees; its 1967 Protocol; the 1969 OAU Convention Governing 
the Specific Aspects of Refugee Problems in Africa; those recognized in 
accordance with the UNHCR Statute; individuals granted complementary forms 
of protection; or those enjoying temporary protection”. 
o Internally displaced persons (IDPs) “are people or groups of individuals who have 
been forced to leave their homes or places of habitual residence, in particular as a 
result of, or in order to avoid the effects of armed conflict, situations of 
generalized violence, violations of human rights, or natural or man-made 
disasters, and who have not crossed an international border”. 
Therefore, the Table 6 (Annex 2) includes information of 2015 about the number of 
Nigerian refugees (broken down in refugees, refugees-like situations, assisted by the 
UNHCR and asylum seekers-pending cases); IDPs and others of concerned. 
- Nigerian refugees and people in a refugee-like situation, excluding asylum-seekers, and 
changes by country of asylum, 2015, the countries of asylum for Nigerians in 2015 were 
the following: 
o Cameroon 
o Canada 
o Chad 
o France 
o Italy 
o Niger 
o UK
 
 Population start-2015   Population end-2015  
 TOTAL  
  of whom: 
UNHCR-assisted  
 TOTAL  
  of whom: 
UNHCR-assisted  
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Table 7 (Annex 2) gives two different points of information: the number of Nigerian 
refugees at the beginning of 2015 and at the end of 2015 by country of asylum, and it also 
includes the number of refugees of those that were assisted by the foundation. 
In addition, as a complement for the variables defined above, inside the other UN’s 
database mentioned before, an historic of Nigerian migrants from 1990-2013 by place of 
asylum was recovered in order to have a broader mind of the situation. 
- Total migrant stock at mid-year of Nigeria by major area, region, country or area of 
destination, 1990 – 2013, which principal areas and regions of study are the following: 
o More developed regions 
o Less developed regions 
o Sub-Saharan Africa 
o Africa (North, South, 
East, West, Middle 
Country/ Territory of 
Asylum  
Cameroon                 39.968                  24.874                  71.840                  71.840  
Canada                  4.683                         -                    4.502                         -   
Chad                  2.930                   2.327                   5.689                   5.689  
France                  1.102                         -                    1.250                         -   
Italy                  6.293                         -                    9.931                         -   
Niger                 30.000                  30.000                  68.321                  68.321  
United Kingdom                  1.471                         -                    1.679                         -   
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Nigeria 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
GDP per capita, PPP (constant 2011 international $) 4352,80 4528,86 4686,61 4879,48 5122,81 5230,60 5309,52 5447,76 5639,45 5638,89
GDP growth (annual %) 8,21% 6,83% 6,27% 6,93% 7,84% 4,89% 4,28% 5,39% 6,31% 2,65%
Population growth (annual %) 2,62% 2,64% 2,66% 2,67% 2,68% 2,69% 2,69% 2,68% 2,66% 2,63%
Population, total, millions 143,32 147,15 151,12 155,21 159,42 163,77 168,24 172,82 177,48 182,20
Mortality rate, under-5 (per 1,000 live births) 152,20 146,40 140,90 135,50 130,30 125,50 120,90 116,60 112,50 108,80
Life expectancy at birth, total (years) 49,24 49,81 50,36 50,87 51,33 51,74 52,11 52,44 52,75 ..
Ghana 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
GDP per capita, PPP (constant 2011 international $) 2651,39 2695,88 2867,72 2930,95 3083,87 3430,86 3659,24 3833,79 3894,00 3954,52
GDP growth (annual %) 6,40% 4,35% 9,15% 4,85% 7,90% 14,05% 9,29% 7,31% 3,99% 3,92%
Population growth (annual %) 2,60% 2,59% 2,58% 2,55% 2,52% 2,48% 2,44% 2,40% 2,35% 2,30%
Population, total, millions 21,95 22,53 23,12 23,71 24,32 24,93 25,54 26,16 26,79 27,41
Mortality rate, under-5 (per 1,000 live births) 84,40 82,20 79,90 77,40 74,70 71,90 69,20 66,50 64,00 61,60
Life expectancy at birth, total (years) 59,18 59,64 60,03 60,36 60,61 60,81 60,98 61,14 61,31 ..
Sub-Saharan Africa 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
GDP per capita, PPP (constant 2011 international $) 2928,82 3051,32 3132,80 3149,07 3238,42 3292,91 3326,47 3399,69 3470,52 3488,27
GDP growth (annual %) 7,05% 7,07% 5,39% 2,85% 5,39% 4,32% 3,72% 4,76% 4,59% 3,01%
Population growth (annual %) 2,74% 2,76% 2,77% 2,77% 2,77% 2,77% 2,77% 2,76% 2,75% 2,73%
Population, total, millions 783,40 805,00 827,20 850,20 873,80 898,00 922,80 948,30 974,40 1000,90
Mortality rate, under-5 (per 1,000 live births) 121,71 116,32 111,12 106,16 101,40 97,08 93,02 89,36 86,06 83,18
Life expectancy at birth, total (years) 53,43 54,18 54,93 55,65 56,33 56,97 57,55 58,08 58,56 ..
Middle & Low Income Countries 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
GDP per capita, PPP (constant 2011 international $) 6483,10 6957,70 7255,75 7371,15 7828,89 8185,52 8482,10 8798,30 9090,40 9349,44
GDP growth (annual %) 8,09% 8,68% 5,69% 2,37% 7,54% 5,99% 4,88% 4,95% 4,31% 3,72%
Population growth (annual %) 1,34% 1,32% 1,32% 1,32% 1,32% 1,32% 1,32% 1,32% 1,32% 1,30%
Population, total, millions 5474,18 5546,49 5619,63 5693,95 5769,21 5845,58 5922,88 6001,16 6080,18 6159,44
Mortality rate, under-5 (per 1,000 live births) 66,30 63,70 61,50 58,90 56,90 54,30 52,00 49,90 48,00 46,40
Life expectancy at birth, total (years) 67,36 67,69 68,00 68,32 68,61 68,91 69,19 69,44 69,68 ..
Latin America & Caribbean 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
GDP per capita, PPP (constant 2011 international $) 12700,35 13256,38 13602,96 13194,67 13795,65 14239,62 14485,04 14732,91 14716,77 14596,57
GDP growth (annual %) 5,32% 5,71% 3,98% -1,73% 5,80% 4,38% 2,83% 2,78% 0,74% -0,29%
Population growth (annual %) 1,29% 1,27% 1,25% 1,22% 1,20% 1,17% 1,15% 1,12% 1,09% 1,07%
Population, total, millions 570,05 577,27 584,50 591,60 598,70 605,70 612,60 619,51 626,29 633,00
Mortality rate, under-5 (per 1,000 live births) 23,66 22,76 21,93 21,18 23,66 19,87 19,30 18,78 18,35 17,96
Life expectancy at birth, total (years) 73,15 73,38 73,60 73,82 74,04 74,26 74,49 74,71 74,94 ..
Table 1. Development indicators 2006-2015  
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4.  Investments and Incidence: a comparative analysis  
This section is devoted to see the evolution of health investments made and the incidence 
of the researched diseases in the countries of interest and worldwide regions. 
4.1 Regions of Study 
Nigeria and Ghana are countries where the incidence of diseases as malaria, malnutrition 
and HIV is significant, and many efforts have been made in order to ameliorate the 
situation. NGOS, Governmental Institutions, individual volunteers; have invested their 
time and their economic resources in those countries for making civilians’ life better. In 
fact, international health investments summed up 810 million USD2014 in Nigeria and 156 
million USD2014 in Ghana during 2015.1  
Nigerian health investments represented in 2015 the 11% of total health investments in 
Africa and more than the 6% of total health investments in Developing Countries. The 
figure is even more significant when talking about malaria investments, in 2015 the 14% 
of the money invested in Africa and almost the 12% of the investments in developing 
countries in malaria were for Nigeria. Nevertheless, the figures are less impressive 
referring to basic nutrition investments, Nigeria represented in 2015 only a 3% of the 
African investments and less than a 2% of Developing Countries’ investments in this 
issue. As for investments in Sexually Transmitted Diseases (STD), where HIV is the 
principal component, Nigerian investments represented in 2015 the 10% and the 6% of 
the investments for this purpose in Africa and Developing Countries respectively (Annex 
1) 
In the case of Ghana, health investments represented in 2015 a 2% and 1% of total health 
investments in Africa and Developing Countries respectively. The percentages are 6% 
and 5% when they are referred to malaria investments. In the case of Ghana, the 
investments made in Basic Nutrition are higher than the ones made in STD Control, but 
both lower than malaria investments. Ghanaian investments in STD Control did not reach 
the 1% of Developing Countries’ investments in this issue in 2015, and were the 1% of 
African investments. Regarding basic nutrition investments, in 2015 the 2% of the money 
                                                 
1 OECD. (2016). OECD Stats. Retrieved from https://stats.oecd.org/Index.aspx?DataSetCode=CRS1 
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invested in Africa and the 1% of the investments in developing countries were for Ghana 
(Annex 1:  
Table 4) 
 
 
 
Table 5). During the following sections we will see the evolution of both the health 
incidence and the health investments made in the regions of study. 
4.2. Evolution of Donations 
A World Overview  
As we can derive from Figure 1, Health investments have increased during the period 
2006-2015 in Developing Countries as an average, but also in Africa; whereas the 
American investments have been more stable along time. We can see a peak in total health 
investments in 2013 for Developing Countries and Africa; while in America the peak 
happened two years before in 2011. The trend followed by African health investments is 
very similar to the one of Developing Countries, in fact, both regions focused first on 
STD Control (including HIV/AIDS) and afterwards in Malaria, leaving Basic Nutrition 
in the third place. On the other hand, in America the second and third place are 
interchanged. In addition, Africa is the developing region where most of the investments 
go during the whole period. In fact, approximately half of total health investments in the 
developing world are made in Africa, and the number is even higher when it refers to 
Malaria investments where the average is almost an 80% and STD control where it comes 
upon the 60%. The investments made in America are residual in comparison, with the 
highest number in Basic Nutrition investments, that round the 10% of total developing 
countries’ investments in average for the period selected, nonetheless Africa’s figure is 
higher in nutrition too surpassing the 50% of average. 
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Figure 1. Health Investments 2006-2015, a World Overview 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
As for the portion that the investments made in the different regions in malaria, HIV and 
basic nutrition represent as part of the total health investments made, we can see in Figure 2 
that HIV investments are the ones with the highest proportion in the three regions, but with 
a decreasing trend among the years of study (2006-2015). In Developing countries and 
America, HIV investments round in average the 40% of total health investments, whilst in 
Africa the number is even higher, approximately the 50%.  
Regarding malaria control investments, we observe an increasing trend in the three regions, 
nonetheless the investments have been stagnated or have decrease in the case of America 
since the middle of the period (2011-2012). The portion that the malaria investments 
represent as total investments is much lower if we compare it to HIV investments. In fact, 
malaria investments represent an 8%, 12% and 3% on average to total health investments in 
developing countries, Africa and America respectively. 
In terms of basic nutrition investments, there is an increasing trend over time, with a high 
fluctuation in America. Basic nutrition investments represent a 3%, 3% and 7% on average 
to total health investments in developing countries, Africa and America respectively. 
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Figure 2. Malaria, Basic Nutrition and HIV Investments over Total Health Investments 2006-2015, a World 
Overview 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
For more information see Annex 6, where a more detailed situation of health investments 
worldwide is provided in different figures and tables. 
 
 Nigeria 
Nigerian health investments have also followed the pattern of African health investments, 
see Figure 3, where STD Control (including HIV/AIDS) is the most financed disease, 
followed by malaria investments, while the investments made in basic nutrition are 
insignificant in comparison. In addition, we observe a positive pattern in the investments of 
the three main diseases of study from 2006 to 2015, with some variabilities, as for the peak 
in malaria investments from $201449 million in 2008 to $2014336 million in 2009 and to $201464 
million in 2010. 
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Figure 3. Nigerian Health Investments 2006-2015 (thousands of 2014 USD) 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
Investments in STD Control (including HIV/AIDS), mainly devoted to battle HIV; have 
increased from $2014200 million in 2006 to $2014372 million in 2015; which account for the 
53% and 32% of the total health investments respectively. The decreasing presence of HIV 
as part of total health investments as seen in Figure 4, has to do with the fact that donations 
in other areas of health are being made, as for malaria.  As for investments in Malaria Control, 
they have increased from $201452 million in 2006 to $2014220 million in 2015, representing the 
4% and 19% of total health investments made in Nigeria respectively. Finally, regarding 
investments in Basic Nutrition, we can observe that they have increased from $20142 million 
in 2006 to $201415 million in 2015, doubling its presence as part of total health investments, 
from 0.6% to 1.3% respectively. 
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Figure 4. Nigerian Health Investments 2006-2015 (% of Total Health Investments) 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
To conclude, Nigerian investments in health focused at first in the battle against HIV and 
AIDS, even though HIV is still the major health investment made in Nigeria, malaria 
control is increasing its presence too, while basic nutrition investments against stunting 
were and still are minimal in the country. (Figures 3 and 4) 
Ghana 
Ghanaian health investments have followed a different pattern, see Figure 5. In Ghana, 
STD Control (including HIV/AIDS) was at first the most financed disease until 2009 
where malaria investments took the lead. In addition, investments made in basic nutrition 
were and still are in third position, but the disbursement is higher. The variability in 
Ghanaian health investments is very high, and we can see a periodic pattern of around 
two years in the ups and downs. From 2006 to 2015, the trend in malaria investments and 
basic nutrition investments is positive, whereas the trend in STD Control is flat, as seen 
in figure 5. 
 
 
 
 
0,00%
10,00%
20,00%
30,00%
40,00%
50,00%
60,00%
70,00%
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
NIGERIAN MALARIA, BASIC NUTRITION AND HIV INVESTMENTS 
OVER TOTAL HEALTH INVESTMENTS
Nigeria Malaria Control Nigeria Basic Nutrition Nigeria Std Control including HIV/AIDS
 
24 
 
 
 
 
Figure 5. Ghanaian Health Investments 2006-2015 (Thousands of 2014 USD) 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
Investments in STD Control (including HIV/AIDS), mainly devoted to battle HIV; have 
remained similar from $201438 million in 2006 to $201440 million in 2015; which account 
for the 22% and 18% of the total health investments respectively. As for investments in 
Malaria Control, they have increased from $20146 million in 2006 to $201486 million in 
2015, representing the 3,5% and 38% of total health investments made in Nigeria 
respectively. Finally, regarding investments in Basic Nutrition, we can observe that they 
have increased from $20140,9 million in 2006 to $201411 million in 2015, multiplying its 
presence as part of total health investments, from 0.5% to 5% respectively. 
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Figure 6. Ghanaian Health Investments 2006-2015 (% of Total Health Investments) 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
To conclude, Ghanaian health investments in health focused at first in the battle against 
HIV and AIDS until 2009. Malaria control is the leading cause of health investments in 
the country, while basic nutrition investments against stunting were minimal and are 
increasing its presence and budget (Figures 5 and 6). 
4. 3.  Evolution of Incidence 
 A World Overview  
Malnutrition 
In developing countries, there is a decreasing trend in the incidence of child malnutrition, 
more concrete in the proportion of stunted children under five years old, as we can see in 
Figure 7 (grey line). In fact, there is a decrease of almost a 7% from 2005 to 2015. 
Africa and America follow the same decreasing trend as Developing Countries, but the 
numbers are quite different. Africa is above the incidence of developing countries during 
the whole period with numbers rounding the 40% of stunted children; whereas America 
is quite below, with numbers approaching the 10% of stunted children and lower.  
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Figure 7. Child Malnutrition Incidence 2005-2015, a World Overview (% of stunted children <5) 
 
Source: Own elaboration based on data from the Word Health Organization’s dataset, the Global Health Observatory (GHO) 
data (http://apps.who.int/gho/data/node.homehttp://databank.worldbank.org/) 
 
 
Malaria 
As for malaria incidence, the same pattern as basic nutrition incidence is followed, as 
shown in Figure 8. In this case, we measure the incidence of malaria per 1,000 population 
at risk. Sub-Saharan Africa is the region with the highest incidence during the whole 
period, from 2000 to 2015, from more than 400 to less than 250 new people infected per 
1,000 population at risk respectively; which represents almost a 45% decrease in fifteen 
years. 
The incidence of malaria in ‘Low & middle-income countries’ is much smaller, from 
more than 150 to less than 100 new people infected per 1,000 population at risk in 2000 
and 2015 respectively. Africa’s incidence in malaria was 2.7 times greater than Low & 
middle-income countries incidence; this number diminished to 2.5 in 2015.  
As for the incidence of malaria in Latin American & Caribbean, is minimal, as seen in 
Figure 8. In fact, the incidence does not arrive to 40 in 2000, and rounds 10 in 2015. 
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Figure 8. Malaria Incidence 2000-2015, a World Overview (per 1,000 population at risk) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
 
HIV 
HIV incidence is measured by the number of new infections among uninfected population 
of 15 to 49 years old expressed as percentage. As we can derive from Figure 9, HIV 
incidence in Sub-Saharan Africa is very high in comparison to Latin American & 
Caribbean. In Africa in 2000, 0.69 %, which means that there were 0.69 new infections 
over 100-uninfected population from 15 to 49 years old. This number diminishes along 
time by more than half, until the 0.30% of 2015. 
The trend followed by Latin America and Caribbean in HIV incidence is slightly 
different; it also has a decreasing slope, but is flatter over time, going from 0.046% to 
0.031% in the analyzed period, 
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Figure 9. HIV Incidence 2000-2015, a World Overview (% of infected population ages 15-49) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
 
 
Nigeria 
Malnutrition 
The proportion of Nigerian stunted children follows the African example, with a 
decreasing trend over time, but with a still high rate nowadays. In fact, as we can see in 
Figure 10, 43% of Nigerian children under 5 years old were stunted in 2003, similar to 
the 40% of 2005 in Africa as a whole. The number has improved, arriving to a 33% of 
stunting incidence in 2014, a 10% less in 11 years. 
Figure 10. Nigerian Child Malnutrition Incidence 2003-2014 (% of stunted children <5) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
Nonetheless, there are significant differences among the stunting incidence in the 
different regions of the country. As derived from Table 2, the regions with the lowest 
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incidence are in the Southern part of the country, with its lowest rate in the South-East 
Zone that in 2014 was only 11%; extremely low compared to the 33% of national average. 
On the other hand, the Northern regions are the ones with the highest rates of stunting, 
specially the North-West Zone where the stunting rate arrived to a 52.7% of children 
under 5 in 2014 and it was even higher before with almost 60% of under 5 children stunted 
in 2003. 
Table 2. Nigerian Prevalence of Stunting by Regions 2003-2014 (% of children <5) 
PREVALENCE OF STUNTING, HEIGHT FOR AGE (% OF CHILDREN UNDER 5) 
 2003 2008 2013 2014 
Nigeria, South South Zone 28 32,8 18,6 20,8 
Nigeria, South West Zone 28,4 32,2 22,4 21,1 
Nigeria, South East Zone 20,3 24,2 16,3 11 
Nigeria, North Central Zone 34,6 44,5 29,3 29,3 
Nigeria, North West Zone 59,7 51,2 53,5 52,7 
Nigeria, North East Zone 47,4 46,9 40,3 48,7 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
 
Malaria 
Malaria incidence in Nigeria is very high, with around 60 million of estimated cases in 
2013, as seen in Figure 11. There is a significant difference with the number of estimated 
cases versus the reported ones, but it is diminishing over time. In 2014, only the 13% of 
the estimated cases was reported, this has to do with the fact that the Administration is 
not recording an exhaustive list of the cases and also that the diagnosis might be 
inaccurate, for a lack of it or for the lack of resources.  
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Figure 11. Nigerian Malaria Incidence 2005-2015 (nº cases) 
  
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/ ), the World 
Health Organization dataset (GOH) (http://apps.who.int/gho/data/node.homehttp://databank.worldbank.org/) 
and the 2016 Malaria Report by the WHO 
 
The same situation arises with the number of malaria deaths, as shown in Figure 12. The 
estimated trend is decreasing over time. The number of estimated malaria deaths in 2013 
was of approximately 120 thousand, from which only the 7% were reported. 
 
Figure 12. Nigerian Malaria Incidence 2005-2014 (nº of Deaths) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/ ), the World 
Health Organization dataset (GOH) (http://apps.who.int/gho/data/node.homehttp://databank.worldbank.org/) 
and the 2016 Malaria Report by the WHO 
 
Moreover, the incidence of malaria in Nigeria has slightly decreased from 2000 to 2015. 
Actually, the number of new malaria cases per 1,000 population at risk decreased from 
almost 500 new cases to 380 in the period of study, as described in Figure 13. 
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Figure 13. Nigerian Malaria Incidence 2000-2015 (new cases per 1,000 population at risk) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
 
HIV 
Concerning Nigerian HIV incidence, we can see the sharply decrease obtained from 2000 
to 2015 in Figure 14. In fact, in 2000, Nigerian incidence was 0.46% versus the 0.69 % 
of African incidence of HIV. In 2000, there were 0.46 new infections in Nigeria over 100-
uninfected population from 15 to 49 years old. The number diminishes by half, arriving 
to the 0.23% of 2015. 
Figure 14. Nigerian HIV Incidence 2000-2015 (% of infected population ages 15-49) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
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Ghana 
Malnutrition 
Ghanaian stunting prevalence is decreasing with time, as seen in Figure 15, where more 
than 35% of Ghanaian children under five were stunted in 2003, compared to the 18.7% 
in 2014. 
Figure 15. Ghanaian Child Malnutrition Incidence 2003-2014 (% of stunted children <5) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
 
Even though the prevalence of stunting is decreasing over time in all the regions of the 
country, there exist differences among them, which are expressed in Table 3. As a matter 
of fact, the Northern part of the country is the one with the highest prevalence of stunting, 
a 37.4% in 2011 higher to the national average of 22.7%. The zone with the lowest 
stunting incidence is Eastern Ghana, with 21.3% of prevalence in 2011. 
 
Table 3. Ghanaian Prevalence of Stunting by Regions 2003-2011(% of children <5) 
PREVALENCE OF STUNTING, HEIGHT FOR AGE (% OF CHILDREN UNDER 5) 
 2003 2006 2008 2011 
Ghana, Central 38,1 33,7 33,9 23,1 
Ghana, Eastern 33,2 28,4 39,3 21,3 
Ghana, Western 33,4 27,4 26 22,6 
Ghana, Northern 54 36,9 32,8 37,4 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
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Malaria 
As in the case of Nigeria, Ghanaian reported cases of malaria are scarce, but the 
Administration is improving it as we can see in Figure 16, where there is a sharp increase 
in the number of reported cases from 2006 to 2015. In addition, we can observe that the 
estimated cases increased from 2005 to 2010, and later decreased in the same proportion 
from 2010 to 2015, leaving the period estimations unchanged in 8.3 million cases in 2013, 
from which only a 20% were reported.  
Figure 16. Ghanaian Malaria Incidence 2005-2015 (nº of cases) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/ ), the World 
Health Organization dataset (GOH) (http://apps.who.int/gho/data/node.homehttp://databank.worldbank.org/) 
and the 2016 Malaria Report by the WHO 
 
An analogous situation arises with the number of malaria deaths, but in this case the 
number of reported and estimated malaria deaths remains nearly constant over time. In 
2013, the number of Ghanaian estimated malaria deaths were 15 thousand, from which a 
17% were reported. 
Figure 17. Ghanaian Malaria Incidence 2005-2014 (nº of deaths) 
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Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/ ), the World 
Health Organization dataset (GOH) (http://apps.who.int/gho/data/node.homehttp://databank.worldbank.org/) 
and the 2016 Malaria Report by the WHO 
 
As regards to the number of new cases of malaria in Ghana, we can state that they suffered 
a significant decrease from 488 new cases per 1,000 people at risk in 2000; to 266 in 
2015; which accounts for a 55% decrease, as seen in Figure 18. 
Figure 18. Ghanaian Malaria Incidence 2000-2015 (nº of new cases per 1,000 population at risk) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
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0.27% over uninfected population (ages 15-49) in 2000 to 0.08% in 2015, as shown in 
Figure 19. 
 
 
 
 
 
 
 
Figure 19. Ghanaian Incidence of HIV 2000-2015(% of infected population ages 15-49) 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) 
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made in the countries of interest, Ghana and Nigeria. The investments in basic nutrition, 
malaria and STD control will be represented in relative terms, as percentage over the total 
health investments of the country, in order to made an adequate comparison, given the 
difference of dimension between the countries.  
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percentage was the 19%. The opposite situation occurs with the investments in Basic 
Nutrition, which are higher in Ghana, representing the 10.5% of total health investments of 
the country in 2014, whilst the figure was only the 2% in Nigeria. Even though the incidence 
of stunted children in Nigeria is higher than in Ghana, 14% higher in 2014; the proportion 
of basic nutrition investments over total health investments is lower in Nigeria, an 8.5% 
lower in 2014. 
 
 
 
Figure 20. Malnutrition in Nigeria & Ghana: Investments vs. Incidence, 2006 - 2015 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) & the OECD’s 
Statistics, CRS (https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
In Figure 21, we can observe that the incidence of malaria in Nigeria is slightly higher along 
the time, in fact, in 2015 there were 381 new cases of malaria per 1,000 population at risk in 
Nigeria towards the 266 of Ghana. Regarding the investments made in malaria control, we 
can observe a high volatility in both countries, but with a dominant lead of Ghana since 2009. 
In 2015, the 38% of investments in health were given over the battle against malaria in 
Ghana, in contrast to the 19% of Nigeria. Even though the incidence of malaria in Nigeria 
is higher than in Ghana, 115 new more cases per 1,000 population at risk in 2014; the 
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proportion of basic nutrition investments over total health investments is lower in Nigeria, 
an 19% lower in 2014. 
 
 
 
 
 
 
 
Figure 21. Malaria in Nigeria & Ghana: Investments vs. Incidence, 2006 - 2015 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) & the OECD’s 
Statistics, CRS (https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
In Figure 22, we can observe a more balanced situation among the investments made towards 
battling HIV and its incidence in both countries, the incidence of HIV in Nigeria is higher 
than in Ghana, so as the investments made in order to combat it.  
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Figure 22. HIV in Nigeria & Ghana: Investments vs. Incidence 
 
Source: Own elaboration based on data from the Word Bank’s DataBank (http://databank.worldbank.org/) & the OECD’s 
Statistics, CRS (https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
 
 
 
 
5. Discussion and Conclusions 
In the study we found a mismatch between the amount of donations directed to Malaria, 
HIV and Malnutrition and the incidence of these diseases in both Nigeria and Ghana.  
HIV keeps having the largest investments, followed by malaria. This is the trend in Africa 
as a region, with an average of 35% of total health investments in 2015, and it is found as 
well in Nigeria, where HIV and malaria investments represented 32% and 19% of total 
health investments in the same year. In Ghana, malaria and HIV are closer in terms of 
investments during the period 2005-2015, so we can say that the prevalence of HIV 
investments is not so clear. In fact, in 2015, malaria investments became larger than HIV 
ones.  Meanwhile, investments in malnutrition are minimal in comparison: just a 1.8% in 
Nigeria and 5% in Ghana as a percentage of total investments in health.   
Large investments in HIV and malaria are justified because their incidence in Africa (and 
in Nigeria and Ghana, in particular) is above the average of developing countries. 
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However, the incidence of malnutrition in these countries is also alarming, and yet, in 
relative and absolute terms, investments do not respond to this need. It seems that 
malnutrition has been neglected in the period 2005-2015.  
While HIV investments in both countries are in accordance to the incidence of the disease, 
the case of malaria is different. Thus, the incidence of malaria is higher in Nigeria than in 
Ghana, but it is Ghana who receives a larger proportion of funds to combat this disease.  
The lack of accordance between funds invested and incidence of the disease is also 
notable within countries. Northern regions of both countries are poorer and show higher 
incidence of HIV; malaria and malnutrition. In the case of Nigeria, this is aggravated by 
the armed conflict situation of the Boko Haram in the North West, which is misplacing 
millions of people to the neighboring areas, as refugees and IDPs. Despite the 
disadvantage of these populations, the Southern regions in both countries are favored in 
terms of health investments. This can be explained by the more favorable trade conditions 
in the Southern regions due to the closeness to the coast. 
Why investments are not being allocated in larger proportion to the countries and regions 
with the largest incidence?  It is not clear. In the case of chronic malnutrition the 
explanation is easier since it is a hidden disease. People do not die directly from chronic 
malnutrition (unless there is a famine and there is acute malnutrition), but it is a condition 
that perpetuates poverty because it affects cognitive and motor development and increase 
susceptibility to get other conditions. The Bill and Melinda Gates foundation is starting 
to raise awareness towards this disease and, therefore, it  might receive more funds in the 
near future.  
HIV raised massive attention, probably because is a condition that can affect everybody, 
the rich and the poor. But chronic malnutrition mostly affects the poor, and malaria is 
more concentrated in poor countries. However, malaria has managed to raise more 
attention in the last decade as reflected in the increasing trend of funds devoted to it and 
the eradication of the disease in 17 countries. The shortage of investments on malaria in 
the case of Nigeria despite its high incidence in the country maybe related to donor 
tiredness. It also happened with polio before. When polio was about to be eradicated, 
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donor´s funds directed towards that condition decreased. Malaria can be wipe out and it 
is necessary to keep investing on it.  
There are other potential reasons for the mismatch between funds and incidence. Some 
authors point out the fashions in the market of development (Shiffman, 2009); others 
mention the politics behind donor investments that guide more money to certain countries 
than others depending on political interests and intertwined purposes (Seo, 2017). It is 
possible that despite the availability of data, donors are not following them. Whatever the 
reasons behind, it is important to  pair the investments wit the incidence of the conditions 
so as to achieve a fair and efficient allocation of resources based on need. 
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ANNEX 1 
In this section, some tables are shown about Nigerian and Ghanaian health investments as percentage of health investments in Africa and 
Developing Countries 2006-2015. 
 
Table 4. Nigerian and Ghanaian Health Investments as % of Total Investments in Developing Countries, 2006-2015 
 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS (https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
 
% of Developing Countries’ Investments 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
Average 
2006-
2015 
Nigeria 
Health total (including HIV) 3,31% 3,75% 4,75% 6,06% 4,11% 4,30% 5,07% 6,16% 5,26% 6,25% 4,90% 
Malaria Control 3,00% 9,77% 5,25% 21,27% 3,75% 6,20% 11,15% 8,28% 15,21% 11,64% 9,55% 
Basic Nutrition  1,10% 0,33% 1,21% 1,26% 0,76% 2,36% 2,08% 2,74% 2,24% 1,63% 1,57% 
STD Control including HIV/AIDS 4,46% 4,67% 6,22% 5,62% 5,87% 4,99% 5,81% 7,40% 6,38% 5,82% 5,72% 
Ghana 
Health total (including HIV) 1,50% 1,35% 1,38% 1,39% 1,31% 1,16% 1,54% 1,35% 1,09% 1,19% 1,33% 
Malaria Control 1,18% 3,91% 2,21% 2,94% 4,48% 2,66% 3,41% 4,39% 2,92% 4,55% 3,27% 
Basic Nutrition  0,46% 0,48% 1,95% 3,76% 1,07% 1,22% 2,24% 0,95% 2,21% 1,17% 1,55% 
STD Control including HIV/AIDS 0,85% 0,81% 0,57% 0,87% 0,46% 0,71% 0,60% 0,73% 0,34% 0,63% 0,66% 
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Table 5. Nigerian and Ghanaian Health Investments as % of Total Investments in Africa Total, 2006-2015 
 
% of African Investments 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
Average 
2006-
2015 
Nigeria 
Health total (including HIV) 7,39% 8,41% 9,04% 11,80% 8,04% 8,33% 9,19% 11,14% 9,27% 10,94% 9,35% 
Malaria Control 3,67% 12,32% 7,04% 26,15% 5,24% 7,98% 14,22% 10,64% 19,31% 14,07% 12,07% 
Basic Nutrition  2,59% 0,91% 2,11% 2,32% 1,33% 4,45% 3,95% 4,73% 3,61% 3,14% 2,91% 
STD Control including HIV/AIDS 8,85% 8,46% 10,25% 9,76% 9,66% 8,85% 9,41% 11,74% 9,76% 10,04% 9,68% 
Ghana 
Health total (including HIV) 3,36% 3,02% 2,63% 2,71% 2,57% 2,25% 2,80% 2,44% 1,92% 2,09% 2,58% 
Malaria Control 1,45% 4,93% 2,97% 3,62% 6,26% 3,42% 4,35% 5,64% 3,70% 5,50% 4,18% 
Basic Nutrition  1,08% 1,35% 3,41% 6,93% 1,87% 2,30% 4,24% 1,64% 3,57% 2,26% 2,87% 
STD Control including HIV/AIDS 1,68% 1,47% 0,95% 1,50% 0,76% 1,26% 0,97% 1,16% 0,52% 1,08% 1,13% 
 
 Source: Own elaboration based on data from the OECD’s Statistics, CRS (https://stats.oecd.org/Index.aspx?DataSetCode
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ANNEX 2 
In this section, some tables about the refugee situation in Nigeria are presented. 
Table 6. Nigerian Refugees and IDPs in 2015 
REFUGEES IDPs Others Total 
Refugees 
People in 
refugee-like 
situations 
Total 
refugees and 
people in 
refugee-like 
situations 
of whom: 
UNHCR-
assisted 
Asylum-
seekers 
(pending 
cases) 
IDPs 
protected/ 
assisted by 
UNHCR, 
incl. people 
in IDP-like 
situations 
Others of 
concern to 
UNHCR 
Total 
population 
of concern 
152.136 15.852 167.988 146.107 51.863 2.172.532 19 2.392.402 
Source: Own elaboration based on data from the UNHCR’s Population Statistics 
(http://popstats.unhcr.org/en/overview#_ga=1.220600017.851890232.1491413062) 
Table 7. Nigerian Refugees by Country of Asylum 2015 
Source: Own elaboration based on data from the UNHCR’s Population Statistics 
(http://popstats.unhcr.org/en/overview#_ga=1.220600017.851890232.1491413062) 
Table 8. Nigerian refugees by Region of Asylum 1990-2013 
Country/Region/Area of 
Destination 
nº of migrants % of total migrants, each year 
1990 2000 2013 
% of total 
1990 
% of total 
2000 
% of 
total 2013 
1. WORLD 465728 625993 1029466 100,00% 100,00% 100,00% 
More developed regions 157326 326323 632782 33,78% 52,13% 61,47% 
Less developed regions 308402 299670 396684 66,22% 47,87% 38,53% 
SUB-SAHARAN AFRICA 288952 279818 362146 62,04% 44,70% 35,18% 
2. AFRICA 291649 282821 366747 62,62% 45,18% 35,62% 
Eastern Africa 302 184 3250 0,06% 0,03% 0,32% 
Middle Africa 129004 121885 154751 27,70% 19,47% 15,03% 
Northern Africa 25768 26888 19876 5,53% 4,30% 1,93% 
Southern Africa 9093 7109 19338 1,95% 1,14% 1,88% 
Western Africa 127482 126755 169532 27,37% 20,25% 16,47% 
Source: Own elaboration based on data from the UN’s World Population Prospects the 2015 Revision 
(https://esa.un.org/unpd/wpp/ 
  
Country/ Territory of 
Asylum  
 Population start-2015   Population end-2015  
 TOTAL  
  of whom: 
UNHCR-assisted  
 TOTAL  
  of whom: 
UNHCR-assisted  
Cameroon                 39.968                  24.874                  71.840                  71.840  
Canada                  4.683                         -                    4.502                         -   
Chad                  2.930                   2.327                   5.689                   5.689  
France                  1.102                         -                    1.250                         -   
Italy                  6.293                         -                    9.931                         -   
Niger                 30.000                  30.000                  68.321                  68.321  
United Kingdom                  1.471                         -                    1.679                         -   
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ANNEX 3 
In this section, a more detailed description about worldwide health investments is 
provided for the following regions, Developing Countries Total, Africa Total and 
America Total; among the years 2006 and 2015. 
Figure 23. Basic Nutrition Investments 2006-2015, a World Overview 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
 
Figure 24. Basic Nutrition Investments over Total Health Investments 2006-2015, a World Overview 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
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Figure 25. Malaria Control Investments 2006-2015, a World Overview 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
 
Figure 26. Malaria Control Investments over Total Health Investments 2006-2015, a World Overview 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
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Figure 27. STD Control Investments (including HIV/AIDS) 2016-2015, a World Overview 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
 
 
 
Figure 28. STD Control Investments over Total Health Investments 2006-2015, a World Overview 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS 
(https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
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Table 9. Africa and America Health Investments as % of Developing Countries' Investments, 2006-2015 
% of Developing Countries’ Investments 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
Average 
2006-
2015 
Africa  
Health total (including HIV) 44,78% 44,62% 52,58% 51,33% 51,05% 51,66% 55,22% 55,28% 56,76% 57,12% 52,04% 
Malaria Control 81,71% 79,25% 74,52% 81,33% 71,50% 77,69% 78,44% 77,84% 78,75% 82,76% 78,38% 
Basic Nutrition  42,65% 35,76% 57,31% 54,33% 57,13% 53,01% 52,76% 57,99% 62,00% 52,02% 52,50% 
Std Control including HIV/AIDS 50,45% 55,26% 60,68% 57,62% 60,72% 56,38% 61,67% 62,99% 65,35% 57,96% 58,91% 
America 
Health total (including HIV) 5,80% 5,26% 5,46% 5,02% 4,84% 5,12% 4,24% 4,45% 5,26% 3,76% 4,92% 
Malaria Control 3,33% 3,10% 2,06% 1,73% 1,99% 3,82% 1,53% 1,15% 1,28% 1,25% 2,13% 
Basic Nutrition  4,47% 5,97% 15,52% 17,59% 9,28% 10,75% 12,59% 9,44% 5,19% 10,13% 10,09% 
Std Control including HIV/AIDS 5,76% 5,17% 4,88% 4,79% 4,55% 4,49% 4,24% 4,44% 3,85% 3,82% 4,60% 
Source: Own elaboration based on data from the OECD’s Statistics, CRS (https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
 
Table 10. Average proportion of Malaria, HIV and Basic Nutrition Investments over Total Health Investments, a World Overview (2006-2015) 
 
Source: Own elaboration based on data from the OECD’s Statistics, CRS (https://stats.oecd.org/Index.aspx?DataSetCode=CRS) 
% of Total Health Investments Including 
HIV/AIDS - average (2006-2015) 
Developing 
Countries 
Total 
Africa Total 
America 
Total 
Malaria Control 8,36% 12,39% 3,30% 
Basic Nutrition  3,20% 3,23% 6,85% 
Std Control including HIV/AIDS 41,97% 47,71% 39,36% 
